Interpace Diagnostics is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States through its Commercial Services business, and developing and commercializing molecular diagnostic tests through its Interpace Diagnostics business. Interpace Diagnostics's Commercial Services is focused on providing outsourced pharmaceutical, biotechnology, medical device and diagnostic sales teams to its corporate customers. Interpace Diagnostics's Interpace Diagnostics is focused on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management.
Closing share price
|FY, 2013||FY, 2014||FY, 2015|
|$150.8 m||$119.9 m||$9.4 m|
Revenue growth, %
|($4.6 m)||($16.1 m)||($11.4 m)|